SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (Pink Sheets:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection provides the following recap of yesterday’s investor conference call, which discussed the Company’s acquisition of intellectual property rights from Los Alamos National Security and how the Company plans to utilize this intellectual property for the development of a revolutionary, handheld integrated optical biosensor capable of highly accurate and rapid HIV/AIDS, malaria, tuberculosis, and other pathogen detection and disease diagnosis.
